Influence on the immune system of homologous blood transfusion and autologous blood donation: Impact on the routine clinical practice/differences in oncological and non-tumour surgery?

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 35, Issue 10, 2000, Pages 642-645

  Nielsen, H J ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; BLOOD AUTOTRANSFUSION; CLINICAL PRACTICE; CONFERENCE PAPER; DISEASE TRANSMISSION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFECTION RISK; ONCOLOGY; SURVIVAL; VIRUS INFECTION;

EID: 0033781003     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7368     Document Type: Conference Paper

References (39)

1. Clinical impact of bioactive substances in blood components: Implications for leukocyte filtration
2. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: Frequent long-term microchimerism in severe trauma patients
3. Role of donor leukocytes and leukodepletion in transfusion-associated viral infections
4. Horizontal transfer of DNA by uptake of apoptotic bodies
5. Blood transfusion is mononuclear cell transplantation
6. Detrimental effect of perioperative blood transfusion
7. Blood transfusion increases the risk of infection after trauma
8. Surgeons, surgery and immunomodulation
9. Effect of perioperative blood transfusions on recurrence of colorectal cancer. Meta-analysis stratified on risk factors
10. Blood transfusion-related postoperative infections and prognosis after elective colorectal cancer surgery
11. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair
12. Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood
13. Blood transfusion and prognosis in colorectal cancer
14. Adverse reactions associated with autologous blood transfusion: Evaluation and incidence at a large academic hospital
15. The cost effectiveness of preoperative autologous blood donation
16. The role of leucocytes in the systemic inflammatory response and the potential impact of leucocyte reduction
17. Complement activation during storage of whole blood, red cells, plasma and buffy-coat
18. Prestorage leukocyte filtration may reduce leukocyte-derived bioactive substances accumulation in patients operated for burn trauma
19. Histamine-2 receptor antagonist as immunomodulators - New therapeutic views?
20. Absence of host plasminogen activator inhibitor-1 prevents cancer invasion and neovascularisation
21. The prognostic impact of perioperative blood transfusion and preoperative soluble VEGF in patients undergoing resection for primary colorectal cancer
22. Time-dependent histamine release from stored human blood products
23. Time-dependent, spontaneous release of leukocyte- and platelet-derived bioactive substances from stored human blood
24. Leukocyte and platelet derived bioactive substances in stored standard platelet concentrates
25. Leucocyte-derived bioactive substances in fresh frozen plasma
26. Bioactive substances in buffy-coat derived platelets pools stored in platelet additive solutions
27. Soluble vascular endothelial growth factor in various blood transfusion components
28. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates
29. Association of mortality with age of blood transfused in septic ICU patients
30. Immunomodulating effect of blood transfusion. Is blood storage time important?
31. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: Effect of the lenght of storage of transfused red cells
32. The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery
33. The effect of active heating on accumulation of extracellular bioactive substances in transfused blood
34. Reduction of bioactive substances in donor blood. Prestorage versus bedside leucofiltration
35. Prestorage and bedside leukofiltration of whole blood modulates storage time dependent suppression of in vitro TNF-α release
36. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration be leukodepletion
37. Safe and good use of blood in surgery (SANGUIS). Use of blood and artificial colloids in 43 European hospitals
38. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care
39. Perioperative blood transfusion and postoperative mortality